Cardiovascular actions of dogfish Urotensin I in the dogfish, Scyliorhinus canicula

被引:16
作者
Platzack, B
Schaffert, C
Hazon, N
Conlon, JM [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Biomed Sci, Ctr Regulatory Peptide, Omaha, NE 68178 USA
[2] Gothenburg Univ, Dept Zoophysiol, S-41390 Gothenburg, Sweden
[3] Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland
基金
英国惠康基金;
关键词
D O I
10.1006/gcen.1997.7030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A synthetic replicate of dogfish urotensin I (U-I), a 41-amino-acid residue peptide isolated from an extract of the caudal spinal cord region of the European spotted dogfish Scyliorhinus canicula was prepared in order to study its cardiovascular actions in the species of origin. Bolus intraarterial injections of dogfish U-I (0.3-30 nmol/kg body wt) into the celiac artery of unanesthetized dogfish produced a transient fall in arterial blood pressure (P < 0.05 in the dose range 1-3 nmol/kg) followed by a sustained and dose-dependent rise in pressure (P < 0.05 in the dose range 1-30 nmol/kg). The maximum depressor response (to 3 nmol/kg) was 0.25 +/- 0.08 kPa and the maximum presser response (to 30 nmol/kg) was 1.08 +/- 0.09 kPa. There was no significant effect on heart rate at any dose tested. Pretreatment of the animals with the alpha-adrenergic receptor antagonist phentolamine significantly (P < 0.05) attenuated the presser response to injections of dogfish U-I (1 nmol/kg and 10 mol/kg), demonstrating that the effects of the peptide are mediated, at least in part, through release of catecholamines. The data suggest that U-I, released together with potent presser peptide urotensin II from the caudal neurosecretory system, may play a physiological role in cardiovascular regulation in elasmobranchs. (C) 1998 Academic Press.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 29 条
[1]   PHENYLETHANOLAMINE-N-METHYL TRANSFERASE (PNMT) ACTIVITY AND CATECHOLAMINE STORAGE AND RELEASE FROM CHROMAFFIN TISSUE OF THE SPINY DOGFISH, SQUALUS-ACANTHIAS [J].
ABRAHAMSSON, T .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1979, 64 (01) :169-172
[2]  
Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533
[3]  
BERN HA, 1990, PROG CLIN BIOL RES, V342, P242
[4]   CARDIOVASCULAR AND RENAL EFFECTS OF UROTENSINS I AND II IN EEL, ANGUILLA-ROSTRATA [J].
CHAN, DKO .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1975, 27 (01) :52-61
[5]   STRUCTURAL CHARACTERIZATION AND BIOLOGICAL-ACTIVITY OF A NEUROPEPTIDE-Y-RELATED PEPTIDE FROM THE DOGFISH, SCYLIORHINUS-CANICULA [J].
CONLON, JM ;
BALASUBRAMANIAM, A ;
HAZON, N .
ENDOCRINOLOGY, 1991, 128 (05) :2273-2279
[6]  
Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.3.CO
[7]  
2-Y
[8]  
CONLON JM, 1992, NEUROENDOCRINOLOGY, V55, P230
[9]  
CONLON JM, 1990, PEPTIDES, V11, P981
[10]   Cloning and characterization of human urocortin [J].
Donaldson, CJ ;
Sutton, SW ;
Perrin, MH ;
Corrigan, AZ ;
Lewis, KA ;
Rivier, JE ;
Vaughan, JM ;
Vale, WW .
ENDOCRINOLOGY, 1996, 137 (05) :2167-2170